E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2006 in the Prospect News Biotech Daily.

Emisphere granted waiver, extension from lender

By Lisa Kerner

Charlotte, N.C., June 21 - Emisphere Technologies, Inc. was granted a waiver and an extension from lender MHR Institutional Partners II A LP after the company failed to comply with certain provisions of its loan agreement with MHR.

According to an 8-K filing with the Securities and Exchange Commission, the waiver from MHR provided an extension of the required filing date of the registration statement on form S-3.

Emisphere is a biopharmaceutical company located in Tarrytown, N.Y.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.